U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H22O4
Molecular Weight 266.3334
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ANHYDRODIHYDROARTEMISNIN

SMILES

C[C@]1([H])CC[C@@]2([H])C(=CO[C@@]3([H])[C@@]24[C@@]1([H])CC[C@](C)(O3)OO4)C

InChI

InChIKey=UKXCIQFCSITOCY-VLDCTWHGSA-N
InChI=1S/C15H22O4/c1-9-4-5-11-10(2)8-16-13-15(11)12(9)6-7-14(3,17-13)18-19-15/h8-9,11-13H,4-7H2,1-3H3/t9-,11+,12+,13-,14-,15+/m1/s1

HIDE SMILES / InChI

Molecular Formula C15H22O4
Molecular Weight 266.3334
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 6 / 6
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers.
2009 Dec 1
Substance Class Chemical
Created
by admin
on Sat Jun 26 02:23:31 UTC 2021
Edited
by admin
on Sat Jun 26 02:23:31 UTC 2021
Record UNII
0YH8NQO930
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ANHYDRODIHYDROARTEMISNIN
Common Name English
9,10-ANHYDRODEHYDROARTEMISININ
Common Name English
ARTESUNATE IMPURITY C [USP-RC]
Common Name English
DIHYDROARTEMISININ IMPURITY C [USP-RC]
Common Name English
3,12-EPOXY-12H-PYRANO(4,3-J)-1,2-BENZODIOXEPIN, 3,4,5,5A,6,7,8,8A-OCTAHYDRO-3,6,9-TRIMETHYL-, (3R,5AS,6R,8AS,12R,12AR)-
Systematic Name English
(3R,5AS,6R,8AS,12R,12AR)-3,4,5,5A,6,7,8,8A-OCTAHYDRO-3,6,9-TRIMETHYL-3,12-EPOXY-12H-PYRANO(4,3-J)-1,2-BENZODIOXEPIN(+)-9,10
Common Name English
ANHYDRODIHYDROARTEMISININ
Common Name English
ARTESUNATE RELATED COMPOUND C
Common Name English
Code System Code Type Description
PUBCHEM
393517
Created by admin on Sat Jun 26 02:23:31 UTC 2021 , Edited by admin on Sat Jun 26 02:23:31 UTC 2021
PRIMARY
EPA CompTox
82596-30-3
Created by admin on Sat Jun 26 02:23:31 UTC 2021 , Edited by admin on Sat Jun 26 02:23:31 UTC 2021
PRIMARY
CAS
82596-30-3
Created by admin on Sat Jun 26 02:23:31 UTC 2021 , Edited by admin on Sat Jun 26 02:23:31 UTC 2021
PRIMARY
FDA UNII
0YH8NQO930
Created by admin on Sat Jun 26 02:23:31 UTC 2021 , Edited by admin on Sat Jun 26 02:23:31 UTC 2021
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
In the chromatogram obtained with solution (1): the area of any peak corresponding to impurity C, when multiplied by a correction factor of 0.07, is not greater than 0.2 times the area of the principal peak obtained with solution (4) (0.2%) the sum of the corrected area of any peak corresponding to impurity C and the areas of all other peaks, other than the principal peak, is not greater than twice the area of the principal peak obtained with solution (4) (2.0%).
PARENT -> IMPURITY
PARENT -> IMPURITY
PARENT -> IMPURITY